HR
MBIO icon

Howe & Rusling’s Mustang Bio MBIO Stock Holding History

Howe & Rusling’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 732
2022
Q3 		$0 Hold
1
– – ﹤0.01% 1140
2022
Q2 		$0 Hold
1
– – ﹤0.01% 1123
2022
Q1 		$0 Hold
1
– – ﹤0.01% 1046
2021
Q4 		$1K Hold
1
– – ﹤0.01% 937
2021
Q3 		$1K Hold
1
– – ﹤0.01% 926
2021
Q2 		$1K Hold
1
– – ﹤0.01% 888
2021
Q1 		$1K Buy
+1
New +$2.97K ﹤0.01% 894

Other funds holding MBIO

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Howe & Rusling's MBIO Position: Q4 2022 in Review

Howe & Rusling sold out of Mustang Bio (MBIO) in Q4 2022, closing a stake of 1 share.

Howe & Rusling first reported a position in MBIO in Q1 2021 and held it in 7 quarters. The position peaked at $1K in Q4 2021. 60 funds tracked by Wall St. Rank hold MBIO as of Q4 2022.

  • Howe & Rusling reported no remaining Mustang Bio position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 1 Mustang Bio share in Q4 2022.
  • Howe & Rusling first reported a position in Mustang Bio in Q1 2021 and held it in 7 quarters.
  • Howe & Rusling's Mustang Bio position peaked at $1K in Q4 2021.
  • 60 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.